Sonic Healthcare (ASX:SHL) share price struggles despite COVID passport positioning

The Sonic Healthcare share price tumbled from a record open this morning. Let's take a closer look.

| More on:
a doctor with stethoscope around neck sits as a computer with head in hand, looking despondent.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sonic Healthcare Limited (ASX: SHL) share price faded its morning gains after opening 2.88% higher to a new all-time high of $43.95.

At the time of writing, shares in the medical diagnostics company are flat at $42.72.

Sonic Healthcare positioned to perform COVID-19 testing for vaccine passport

Sonic Healthcare has played a crucial role in pandemic control, performing ~30 million COVID PCT tests from March 2020 to date.

According to the Australian Financial Review (AFR), Sonic Healthcare is "positioning itself as the top contender to conduct the COVID-19 testing for an eventual "vaccine passport" if there is a government tender process".

Sonic Healthcare CEO Colin Goldschmidt told the AFR that "While there has not been any signal from the government about such a tender process, at the moment the airlines are trying to co-ordinate since they don't want COVID-19 infected travellers on the plane,".

"It's early days, but we are very much investigating what sort of role we can play in terms of travel passports, vaccination and testing, and then linking in with international air carriers. It's a big and complicated area," he said.

COVID-19 testing lifting Sonic Healthcare's earnings

Sonic Healthcare said in its FY21 results that COVID-19 testing has enhanced its financial performance.

As a result, the company's revenue increased 28% to $8.8 billion while net profit surged 149% to $1.3 billion.

Despite a strong financial performance, the Sonic Healthcare share price fell 2.76% to $41.65 on the day of the announcement.

One potential concern is the company's increasing dependency on COVID-19 testing.

Sonic Healthcare flagged that COVID-19 PCR volumes were lower in the second half of the year versus the first half, but have been increasing post-year end with the spread of the Delta variant.

Sonic Healthcare share price snapshot

The Sonic Healthcare share price is up 29.91% year-to-date and 33% in the past 12-months.

The company's shares will go ex-dividend on Tuesday 7 September for 55 cents per share. Investors can expect the dividend to be paid out on Wednesday 22 September.

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Male investor holds a microscope to his eye to represent scrutiny of Wesfarmers share price
Healthcare Shares

Mesoblast shares: Bull vs. bear

Two experts have presented their case for buying and selling the ASX biotech stock.

Read more »

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

Should I buy Sigma Healthcare shares for the Chemist Warehouse exposure?

Is this ASX stock a healthy buying opportunity?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

Should I buy CSL shares in December?

After a big fall, is this now the time to jump on CSL shares?

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Earnings Results

Fisher & Paykel shares surge 8% on half-year results

The market's response was in appreciation of strong results and upgraded guidance.

Read more »

Biotechnology spelt out on green blocks.
Healthcare Shares

Are CSL shares a buy amid the company's $500 million cost-cutting plans?

A leading investment expert delivers his verdict on the outlook for CSL’s beaten-down shares.

Read more »

These three ASX mining shares rocketed by more than 20% today
Healthcare Shares

Guess which $7 billion ASX 200 healthcare share is leaping 14% today

Investors are piling into this ASX 200 healthcare stock on Tuesday. But why?

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Healthcare Shares

Mesoblast shares push higher on strong sales update

Sales are growing for this biotech. Let's see what it reported today.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

This Aussie fertility company has rejected a takeover bid from private equity

Monash IVF has rejected a takeover offer from private equity, saying the bid significantly undervalues the IVF company.

Read more »